Search

Author/Creator Barry, Simon T

1. CXCR2 inhibition enables NASH-HCC immunotherapy. Issue 10 (27th April 2022)

Authors:
Leslie, Jack; Mackey, John B G; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; Pinyol, Roser; Esteban-Fabró, Roger; Willoughby, Catherine E; Haber, Philipp K; Andreu-Oller, Carmen; ...
Journal:
Gut
Issue:
Volume 71:Issue 10(2022)
Page Start:
2093
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Issue 4 (6th April 2022)

Authors:
Revenko, Alexey; Carnevalli, Larissa S; Sinclair, Charles; Johnson, Ben; Peter, Alison; Taylor, Molly; Hettrick, Lisa; Chapman, Melissa; Klein, Stephanie; Solanki, Anisha; Gattis, Danielle; Watt, Andrew; Hughes, Adina M; Magiera, Lukasz; Kar, Gozde; Ireland, Lucy; Mele, Deanna A; Sah, Vasu; Singh...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. Issue 3 (30th July 2019)

Authors:
Reader, Claire S; Vallath, Sabari; Steele, Colin W; Haider, Syed; Brentnall, Adam; Desai, Ami; Moore, Kate M; Jamieson, Nigel B; Chang, David; Bailey, Peter; Scarpa, Aldo; Lawlor, Rita; Chelala, Claude; Keyse, Stephen M; Biankin, Andrew; Morton, Jennifer P; Evans, TR Jeffry; Barry, Simon T; Sanso...
Journal:
Journal of pathology
Issue:
Volume 249:Issue 3(2019)
Page Start:
332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗